Bragar Eagel &amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix ( TLX ) To Contact Him Directly To Discuss Their Options

<p>Bragar Eagel & Squire, P.C. 正在代表其股東調查 Telix Pharmaceuticals Limited，原因是可能違反聯邦證券法。此次調查是在 Telix 披露了來自 SEC 的傳票後進行的，該傳票涉及其前列腺癌治療候選藥物，這導致其 ADR 價格下跌了 10.44%。遭受損失的投資者被鼓勵聯繫該公司以尋求法律選項</p>

TELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Telix Pharmaceuticals Limited on Behalf of Telix Stockholders and Encourages Investors to Contact the Firm

TELIX 警報：Bragar Eagel & Squire, P.C. 正在代表 Telix Pharmaceuticals 的股東進行調查，並鼓勵投資者與該律所聯繫